Vagus Nerve Stimulation for Treatment-Resistant\nDepression: A Randomized, Controlled Acute\nPhase Trial
The University of Texas Southwestern Medical Center · Baylor College of Medicine · +17 more institutions
Abstract
Background: Vagus nerve stimulation (VNS) alters both concentrations of neurotransmitters or their metabolites and functional activity of central nervous system regions dysregulated in mood disorders. An open trial has suggested efficacy.\nMethods: This 10-week, acute, randomized, controlled, masked trial compared adjunctive VNS with sham treatment in 235 outpatients with nonpsychotic major depressive disorder (n = 210) or nonpsychotic, depressed phase, bipolar disorder (n = 25). In the current episode, participants had not responded adequately to between two and six research-qualified medication trials. A two-week, single-blind recovery period (no stimulation) and then 10 weeks of masked active or sham VNS…
Citation impact
- FWCI
- 38.16
- Percentile
- 100%
- References
- 42
Authors
16- AJA. John RushCorresponding
The University of Texas Southwestern Medical Center
- LBLauren B. Marangell
Baylor College of Medicine
- HAHarold A. Sackeïm
New York Psychoanalytic Society and Institute, New York State Psychiatric Institute, Columbia University
- MSMark S. George
Medical University of South Carolina, Ralph H. Johnson VA Medical Center
- SKStephen K. Brannan
Topics & keywords
- Vagus nerve stimulation
- Depression (economics)
- Treatment-resistant depression
- Randomized controlled trial
- Hamilton Rating Scale for Depression
- Psychology
- Adverse effect
- Major depressive disorder
- Good health and well-being